EssilorLuxottica Achieves Second-Quarter and First-Half 2025 Revenue Growth, Points to Innovations in Med-Tech Space

Published on July 29, 2025
PARIS—EssilorLuxottica (Euronext: EL) on Monday announced its second-quarter and first-half 2025 results for the period ending June 30, 2025. The company reported 7.3 percent revenue growth (constant exchange rates) in both the second quarter and the first half of the year. For the first six months of 2025, total revenue reached €14,024 million, while second-quarter 2025 revenue was €7,175 million. Adjusted operating margins were stable at 18.3 percent in the first half, and sound free cash flow generation was reported at €951 million.
Continue reading on website
Other news

CooperVision recognized during 2025 Puerto Rico Manufacturers Association Awards

July 28, 2025
The company was presented with the PRMA President’s Award, Platinum Recycling Award, and recognitions in Leadership in Environmental Performance.

Case report: Gyrate atrophy of the choroid and retina

July 29, 2025
Gyrate atrophy of the choroid and retina is a form of choroidal sclerosis and is a rare, progressive, autosomal recessive, inherited genetic disease that primarily affects the ocular tissue.